2023 annual financial data
BioNTech SE 2023 Operating margin
BioNTech SE 2023 operating margin with verified reported values.
Direct answer
Operating margin was 18.08%.
Operating income was 690,400,000 EUR and net income was 930,300,000 EUR.
Operating cash flow was 5,371,400,000 EUR.
Get free BioNTech SE email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,819,000,000 EUR
- Operating income
- 690,400,000 EUR
- Net income
- 930,300,000 EUR
- Operating cash flow
- 5,371,400,000 EUR